Bio-Techne (TECH) Non-Current Deferred Tax Liability (2011 - 2026)

Bio-Techne has reported Non-Current Deferred Tax Liability for 16 years, with the latest figure at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 55.49% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (down 55.49% YoY), and the FY2025 full-year result was $6.2 million, down 88.96% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $14.2 million, up from $11.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $112.9 million in Q3 2022, with the low at $4.1 million in Q3 2023.
• Average Non-Current Deferred Tax Liability over 5 years is $56.7 million, with a median of $55.9 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability plunged 96.37% in 2023 and jumped 1119.93% in 2024.
• Tracing TECH's Non-Current Deferred Tax Liability over 5 years: stood at $111.4 million in 2022, then tumbled by 35.74% to $71.6 million in 2023, then sank by 47.3% to $37.7 million in 2024, then sank by 70.78% to $11.0 million in 2025, then gained by 28.94% to $14.2 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $14.2 million (Q1 2026), $11.0 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.

Peer Comparison